OSUR - OraSure Technologies Inc Stock Price, Fair Value and News

4.92USD-0.31 (-5.93%)Delayed

Market Summary

USD4.92-0.31

Delayed

-5.93%

OSUR Alerts

Big fall in Revenue (Y/Y)

Big fall in earnings (Y/Y)
Losses in recent quarter

OSUR Stock Price

View Fullscreen

OSUR RSI Chart

OSUR Valuation

Market Cap

363.9M

Price/Earnings (Trailing)

15.92

Price/Sales (Trailing)

1.19

EV/EBITDA

2.56

Price/Free Cashflow

2.67

OSUR Price/Sales (Trailing)

OSUR Profitability

EBT Margin

8.42%

Return on Equity

5.36%

Return on Assets

4.89%

Free Cashflow Yield

37.41%

OSUR Fundamentals

OSUR Revenue

Revenue (TTM)

304.6M

Rev. Growth (Yr)

-65.07%

Rev. Growth (Qtr)

-28.66%

OSUR Earnings

Earnings (TTM)

22.9M

Earnings Growth (Yr)

-113.17%

Earnings Growth (Qtr)

-117.85%

Breaking Down OSUR Revenue

Last 7 days

1.2%

Last 30 days

-6.3%

Last 90 days

-27.1%

Trailing 12 Months

-8.2%

How does OSUR drawdown profile look like?

OSUR Financial Health

Current Ratio

11.97

OSUR Investor Care

Shares Dilution (1Y)

0.95%

Diluted EPS (TTM)

0.3

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	304.6M	0	0	0
2023	474.7M	479.9M	452.7M	405.5M
2022	242.8M	265.4M	328.0M	387.5M
2021	199.4M	227.1M	233.0M	233.7M
2020	156.1M	146.5M	154.9M	171.7M
2019	169.9M	165.1M	155.2M	154.6M
2018	176.5M	180.0M	183.5M	181.7M
2017	131.7M	140.5M	150.5M	167.1M
2016	121.7M	122.7M	125.1M	128.2M
2015	110.0M	114.0M	116.0M	119.7M
2014	101.3M	103.4M	106.6M	106.5M
2013	88.0M	89.8M	92.3M	98.9M
2012	85.4M	89.0M	89.4M	87.8M
2011	74.5M	74.3M	77.0M	81.9M
2010	0	76.4M	75.7M	75.0M
2009	0	0	0	77.0M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of OraSure Technologies Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 26, 2024	datin james a	acquired	20,001	6.2175	3,217	-
Mar 26, 2024	datin james a	sold (taxes)	-5,415	6.2175	-871	-
Mar 01, 2024	mcgrath kenneth j	acquired	-	-	58,759	chief financial officer
Mar 01, 2024	weber kathleen gallagher	sold (taxes)	-31,668	7.1925	-4,403	chief product officer
Mar 01, 2024	eglinton manner carrie	sold (taxes)	-213,236	7.1925	-29,647	president & ceo
Mar 01, 2024	mcgrath kenneth j	sold (taxes)	-40,393	7.1925	-5,616	chief financial officer
Mar 01, 2024	anthony michele marie	sold (taxes)	-19,477	7.1925	-2,708	svp finance & cao
Mar 01, 2024	eglinton manner carrie	acquired	-	-	260,688	president & ceo
Mar 01, 2024	anthony michele marie	acquired	-	-	24,336	svp finance & cao
Mar 01, 2024	weber kathleen gallagher	acquired	-	-	41,171	chief product officer

Which funds bought or sold OSUR recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	SkyView Investment Advisors, LLC	new	-	74,000	74,000	0.01%
May 16, 2024	COMERICA BANK	reduced	-8.99	-90,475	194,575	-%
May 16, 2024	Tidal Investments LLC	new	-	116,303	116,303	-%
May 16, 2024	Pineridge Advisors LLC	sold off	-100	-1,074	-	-%
May 16, 2024	Ancora Advisors LLC	unchanged	-	-5,125	15,375	-%
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-5.05	-182,301	450,887	-%
May 16, 2024	JANE STREET GROUP, LLC	new	-	590,418	590,418	-%
May 15, 2024	Teza Capital Management LLC	new	-	277,740	277,740	0.04%
May 15, 2024	Mariner, LLC	reduced	-4.02	-83,567	214,733	-%
May 15, 2024	DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)	added	32.89	-597	176,843	-%

Are Funds Buying or Selling OSUR?

Are funds buying OSUR calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own OSUR

No. of Funds

Unveiling OraSure Technologies Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	7.23%	5,309,456	SC 13G/A
Feb 09, 2024	dimensional fund advisors lp	5.3%	3,906,687	SC 13G
Jan 22, 2024	blackrock inc.	17.2%	12,622,864	SC 13G/A
Feb 09, 2023	vanguard group inc	7.06%	5,129,077	SC 13G/A
Feb 07, 2023	managed account advisors llc	0.1%	34,069	SC 13G/A
Feb 02, 2023	camber capital management lp	5.85%	2,013	SC 13G
Jan 23, 2023	blackrock inc.	18.9%	13,718,269	SC 13G/A
Feb 08, 2022	earnest partners llc	6.8%	4,871,379	SC 13G
Jan 28, 2022	blackrock inc.	19.3%	13,893,887	SC 13G/A
Jan 26, 2022	managed account advisors llc	6.0%	4,321,379	SC 13G/A

Recent SEC filings of OraSure Technologies Inc

View All Filings

Date Filed	Form Type	Document
May 17, 2024	8-K	Current Report
May 16, 2024	4	Insider Trading
May 16, 2024	4	Insider Trading
May 16, 2024	4	Insider Trading
May 16, 2024	4	Insider Trading
May 16, 2024	4	Insider Trading
May 16, 2024	4	Insider Trading
May 09, 2024	10-Q	Quarterly Report
May 08, 2024	8-K	Current Report
Apr 12, 2024	8-K	Current Report

Peers (Alternatives to OraSure Technologies Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	181.0B	40.3B	-1.75%	-4.07%	32.18	4.49	-2.84%	-3.08%
BDX	68.3B	19.7B	1.78%	-6.05%	51.24	3.46	4.82%	-17.56%
ALGN	20.4B	3.9B	-9.57%	-7.50%	44.2	5.22	5.72%	46.72%
BAX	18.0B	14.9B	-10.73%	-18.01%	6.79	1.21	2.98%	207.68%
MID-CAP
ATR	9.8B	3.5B	6.68%	24.08%	31.27	2.76	6.16%	35.06%
HSIC	9.6B	12.5B	6.31%	-2.51%	24.63	0.77	-0.61%	-18.83%
BIO	8.4B	2.6B	1.13%	-22.65%	-26.02	3.22	-6.25%	-68.62%
XRAY	5.9B	3.9B	-6.79%	-30.12%	-62.84	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	0.52%	31.17%	-216.3	8.9	30.82%	65.57%
PDCO	2.3B	6.6B	0.19%	-5.50%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	5.94%	-10.00%	-1.91	0.41	7.94%	-1661.78%
ANIK	376.6M	169.3M	-1.13%	-2.23%	-4.9	2.23	7.49%	-244.90%
ANGO	241.9M	324.0M	-4.58%	-37.15%	-1.26	0.75	-3.19%	-337.41%
APYX	56.1M	50.5M	22.73%	-73.49%	-2.46	1.11	14.25%	-10.06%
AEMD	1.0M	3.7M	-71.83%	-87.10%	-0.09	0.28	5.77%	8.23%

OraSure Technologies Inc News

Latest updates

OraSure Technologies Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2
Revenue	-28.7%	54.00	76.00	89.00	85.00	155	123	116	80.00	68.00	64.00	54.00	58.00	59.00	63.00	48.00	39.00	29.00	32.00	50.00	36.00	39.00
Gross Profit	-31.5%	24.00	35.00	44.00	26.00	66.00	50.00	47.00	28.00	24.00	27.00	21.00	31.00	38.00	38.00	30.00	-	17.00	16.00	30.00	22.00	25.00
Operating Expenses	-0.2%	31.00	31.00	33.00	33.00	41.00	35.00	46.00	49.00	40.00	37.00	34.00	29.00	28.00	30.00	26.00	-	27.00	24.00	26.00	9.00	20.00
S&GA Expenses	22.3%	8.00	7.00	9.00	9.00	12.00	11.00	13.00	12.00	13.00	11.00	14.00	10.00	10.00	9.00	8.00	-	10.00	7.00	8.00	9.00	8.00
R&D Expenses	10.7%	8.00	7.00	9.00	8.00	11.00	8.00	10.00	9.00	9.00	9.00	9.00	8.00	9.00	10.00	8.00	-	7.00	6.00	6.00	5.00	5.00
EBITDA Margin	-21.3%	0.15*	0.19*	0.16*	0.13*	0.09*	0.00*	-0.08*	-0.16*	-0.09*	0.01*	0.08*	0.15*	-	-	-	-	-	-	-	-	-
Income Taxes	-100.0%	-	1.00	2.00	-0.17	-0.22	-0.17	-1.14	-1.17	4.00	1.00	2.00	4.00	7.00	6.00	4.00	-	1.00	1.00	2.00	1.00	1.00
Earnings Before Taxes	-117.4%	-3.60	21.00	14.00	-4.96	27.00	16.00	4.00	-19.76	-16.00	-8.93	-12.91	2.00	10.00	8.00	5.00	-	-9.18	-6.62	5.00	14.00	6.00
EBT Margin	-39.3%	0.08*	0.14*	0.11*	0.09*	0.06*	-0.04*	-0.12*	-0.22*	-0.15*	-0.04*	0.03*	0.11*	-	-	-	-	-	-	-	-	-
Net Income	-117.9%	-3.58	20.00	11.00	-4.80	27.00	16.00	6.00	-18.59	-19.94	-10.39	-15.01	-1.36	4.00	2.00	1.00	-	-10.49	-7.33	2.00	13.00	4.00
Net Income Margin	-43.3%	0.08*	0.13*	0.11*	0.09*	0.06*	-0.04*	-0.13*	-0.24*	-0.19*	-0.10*	-0.05*	0.02*	-	-	-	-	-	-	-	-	-
Free Cashflow	-87.1%	5.00	40.00	35.00	56.00	5.00	3.00	14.00	-14.89	-56.04	-7.17	-23.70	-10.95	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-3.2%	468	483	458	454	459	444	432	429	436	461	456	465	456	454	436	421	325	349	339	327	319
Current Assets	-9.8%	349	386	356	342	344	325	280	267	268	299	289	285	292	289	303	318	223	225	223	209	205
Cash Equivalents	-14.9%	247	290	218	186	90.00	84.00	75.00	66.00	71.00	117	135	158	178	161	163	174	83.00	76.00	85.00	73.00	70.00
Inventory	-9.3%	43.00	48.00	59.00	73.00	77.00	96.00	79.00	71.00	62.00	53.00	54.00	48.00	40.00	32.00	30.00	28.00	23.00	23.00	25.00	26.00	26.00
Net PPE	-6.2%	43.00	45.00	48.00	49.00	57.00	59.00	85.00	94.00	98.00	73.00	78.00	72.00	65.00	52.00	39.00	34.00	32.00	30.00	29.00	28.00	26.00
Goodwill	-1.5%	35.00	36.00	35.00	36.00	35.00	35.00	34.00	36.00	40.00	40.00	40.00	41.00	40.00	40.00	39.00	35.00	35.00	36.00	29.00	29.00	29.00
Liabilities	-20.8%	41.00	52.00	54.00	59.00	65.00	80.00	90.00	85.00	71.00	80.00	68.00	60.00	53.00	56.00	49.00	39.00	35.00	42.00	38.00	39.00	38.00
Current Liabilities	-26.4%	29.00	40.00	41.00	46.00	55.00	69.00	72.00	65.00	56.00	68.00	54.00	47.00	45.00	46.00	37.00	31.00	26.00	33.00	29.00	30.00	27.00
Shareholder's Equity	-1.0%	426	431	405	394	394	364	342	344	365	381	388	405	404	399	388	382	290	307	301	288	281
Retained Earnings	-4.3%	-87.51	-83.93	-104	-115	-110	-137	-153	-159	-140	-120	-110	-95.04	-93.68	-97.45	-99.31	-100	-89.86	-82.53	-84.97	-98.05	-102
Additional Paid-In Capital	0.3%	531	530	526	524	522	520	518	516	514	511	509	506	505	505	503	499	402	402	401	400	399
Accumulated Depreciation	1.4%	86.00	85.00	84.00	84.00	72.00	70.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shares Outstanding	0.6%	74.00	74.00	73.00	73.00	73.00	73.00	72.00	72.00	72.00	72.00	72.00	72.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	368	-	-	-	198	-	-	-	728	-	-	-	829	-	-	-	570	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-83.7%	6,738	41,366	36,947	57,268	6,002	-18,012	16,299	-9,668	-35,821	-12,784	-19,126	921	-4,393	3,611	4,380	-4,683	2,499	-1,034	6,177	4,133	528
Share Based Compensation	-5.1%	2,968	3,127	2,590	2,357	2,655	2,522	2,296	3,280	3,524	2,652	2,218	1,473	1,464	1,226	1,865	2,672	1,376	774	1,435	617	1,231
Cashflow From Investing	-252.3%	-46,528	30,554	-2,571	37,155	1,016	25,573	-2,224	7,675	-9,939	-6,277	-9,594	-12,295	22,665	-10,113	-17,062	-1,001	14,147	-9,897	8,523	-2,209	-16,214
Cashflow From Financing	-265.4%	-1,297	-355	-705	-632	-1,331	-801	-488	-1,144	-1,395	235	-522	-346	-2,184	929	1,376	94,731	-4,557	-163	-136	-51.00	-4,332
Buy Backs	3747.4%	1,462	38.00	200	460	1,203	246	54.00	905	1,049	189	47.00	147	1,730	12.00	12.00	656	1,408	1.00	7.00	109	3,595

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

OSUR Income Statement

2024-03-31

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
NET REVENUES:
Total revenue	$ 54,132	$ 154,963
COST OF PRODUCTS AND SERVICES SOLD	30,067	89,148
Gross profit	24,065	65,815
OPERATING EXPENSES:
Research and development	7,738	10,560
Sales and marketing	8,448	12,142
General and administrative	11,634	17,711
Loss on impairments	3,338	1,105
Change in the estimated fair value of acquisition-related contingent consideration	0	(24)
Total operating expenses	31,158	41,494
Operating income (loss)	(7,093)	24,321
OTHER INCOME	3,491	2,673
Income (loss) before income taxes	(3,602)	26,994
INCOME TAX BENEFIT	(18)	(225)
NET INCOME (LOSS)	$ (3,584)	$ 27,219
INCOME (LOSS) PER SHARE:
BASIC (in USD per share)	$ (0.05)	$ 0.37
DILUTED (in USD per share)	$ (0.05)	$ 0.37
WEIGHTED-AVERAGE SHARES OUTSTANDING:
BASIC (in shares)	73,947	73,112
DILUTED (in shares)	73,947	73,966
Products and services
NET REVENUES:
Total revenue	$ 53,779	$ 152,914
Other
NET REVENUES:
Total revenue	$ 353	$ 2,049

OSUR Balance Sheet

2024-03-31

Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 247,145,000	$ 290,407,000
Short-term investments	16,627,000	0
Accounts receivable, net of allowance of $1,065 and $1,216	34,037,000	40,171,000
Inventories	43,180,000	47,614,000
Prepaid expenses	4,691,000	6,041,000
Other current assets	2,825,000	2,226,000
Total current assets	348,505,000	386,459,000
Noncurrent Assets:
Property, plant and equipment, net of accumulated depreciation of $86,332 and $85,143	42,597,000	45,420,000
Operating right-of-use assets, net	10,570,000	12,270,000
Finance right-of-use assets, net	158,000	576,000
Intangible assets, net of accumulated amortization of $33,261 and $33,649	1,010,000	1,206,000
Goodwill	35,172,000	35,696,000
Investment in equity method investee	28,333,000	0
Other noncurrent assets	1,213,000	1,218,000
Total noncurrent assets	119,053,000	96,386,000
TOTAL ASSETS	467,558,000	482,845,000
Current Liabilities:
Accounts payable	12,683,000	13,151,000
Deferred revenue	1,597,000	1,559,000
Accrued expenses and other current liabilities	12,715,000	22,710,000
Finance lease liability	517,000	539,000
Operating lease liability	1,593,000	1,577,000
Total current liabilities	29,105,000	39,536,000
Noncurrent Liabilities:
Finance lease liability	204,000	226,000
Operating lease liability	10,676,000	11,162,000
Other noncurrent liabilities	727,000	696,000
Deferred income taxes	595,000	554,000
Total noncurrent liabilities	12,202,000	12,638,000
TOTAL LIABILITIES	41,307,000	52,174,000
Commitments and contingencies (Note 12)
STOCKHOLDERS' EQUITY
Preferred stock, par value $0.000001, 25,000 shares authorized, none issued	0	0
Common stock, par value $0.000001, 120,000 shares authorized, 73,959 and 73,528 shares issued and outstanding	0	0
Additional paid-in capital	531,263,000	529,543,000
Accumulated other comprehensive loss	(17,497,000)	(14,941,000)
Accumulated deficit	(87,515,000)	(83,931,000)
Total stockholders' equity	426,251,000	430,671,000
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 467,558,000	$ 482,845,000

About OraSure Technologies Inc

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's diagnostic products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene Ã‚â€¢ GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene Ã‚â€¢ GUT DNA and RNA collection devices; and OMNIgeneÃ‚â€¢GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.

CEO	Ms. Carrie Eglinton Manner
WEBSITE	orasure.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	840

OraSure Technologies Inc Frequently Asked Questions

What is the ticker symbol for OraSure Technologies Inc? What does OSUR stand for in stocks?

OSUR is the stock ticker symbol of OraSure Technologies Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of OraSure Technologies Inc (OSUR)?

As of Fri May 17 2024, market cap of OraSure Technologies Inc is 363.88 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of OSUR stock?

You can check OSUR's fair value in chart for subscribers.

What is the fair value of OSUR stock?

You can check OSUR's fair value in chart for subscribers. The fair value of OraSure Technologies Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of OraSure Technologies Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for OSUR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is OraSure Technologies Inc a good stock to buy?

The fair value guage provides a quick view whether OSUR is over valued or under valued. Whether OraSure Technologies Inc is cheap or expensive depends on the assumptions which impact OraSure Technologies Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for OSUR.

What is OraSure Technologies Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, OSUR's PE ratio (Price to Earnings) is 15.92 and Price to Sales (PS) ratio is 1.19. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. OSUR PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on OraSure Technologies Inc's stock?

In the past 10 years, OraSure Technologies Inc has provided -0.02 (multiply by 100 for percentage) rate of return.